Lloyd Inc. Recalls Subpotent Thyro-Tab 0.075 mg. Tablets
Lloyd Inc. of Iowa is recalling 1.9 million Thyro-Tab 0.075 mg. tablets due to subpotency and stability issues.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall is classified as FDA Class II and involves a subpotent prescription medication, which poses a risk of harm due to lack of therapeutic effect, fitting the 'High' severity criteria for risk-of-harm products.
Plain-English summary
Lloyd Inc. of Iowa is recalling 1,924,133 Thyro-Tab 0.075 mg. tablets. The product is packaged in 150,000-tablet bulk drums intended for repackaging and is available by prescription. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA.
The recall was initiated because the tablets are subpotent and have a 9-month stability interval. Subpotent medication may not provide the intended therapeutic effect.
Distribution was nationwide and to Puerto Rico. There was no foreign, military, or government distribution. Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider for guidance.
The recalled product
- Product
- Thyro-Tab 0.075 mg., packaged in 150,000-tablet bulk drums for repackaging, RX. The firm name on the label is Lloyd Pharmaceutical, Shenandoah, IA
- Manufacturer
- Lloyd Inc. of Iowa
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot HF23111
Distribution
Part of a larger recall action
This product is one of 4 recalled by Lloyd Inc. of Iowa under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 4 products in this recall →Related recalls
Same manufacturer · Lloyd Inc. of Iowa
See all →- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to cGMP Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Levothroid Tablets Due to Stability Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
Same hazard · subpotency
See all →- ModerateGood Neighbor Pharmacy Earwax Removal Drug Recalled for Low Potency
FDA (Drugs) · 2026-07-22
- ModerateNystatin Cream Recall Due to Low Potency Test Results
FDA (Drugs) · 2026-07-22
- ModerateFoster & Thrive Carbamide Peroxide 6.5% Recalled for Subpotent Strength
FDA (Drugs) · 2026-07-22
- ModerateLeader Carbamide Peroxide Earwax Removal Kit Recalled for Subpotency
FDA (Drugs) · 2026-07-22
- ModerateMeijer Earwax Removal Kit Recalled for Subpotent Active Ingredient
FDA (Drugs) · 2026-07-22
Similar recalls
- SevereLloyd Inc Recalls Subpotent Thyro-Tab 0.75 mg Tablets
FDA (Drugs) · 2012-07-04
- ModerateLloyd Inc Recalls Subpotent Thyro-Tab 0.050mg Bulk Tablets
FDA (Drugs) · 2012-07-04
- SevereLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Control Failures
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Quality Deviations
FDA (Drugs) · 2013-05-29
- ModerateLloyd Inc. Recalls Thyro-Tab Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2012-12-12